SCHEMBL14928893

SCHEMBL14928893

CC[C@H]([C@@H](C)CC)N(O)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.46
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TSHR P16473 3/20 0.42
ALDH1A1 P00352 2/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
SLC6A2 P23975 1/20 0.42
HTR2A P28223 1/20 0.42
SLC6A4 P31645 1/20 0.42
ADRA1A P35348 1/20 0.42
OPRK1 P41145 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KCNH2 Q12809 1/20 0.42
LMNA P02545 1/20 0.41
RIPK1 Q13546 1/20 0.40
HPGD P15428 1/20 0.40
ACE P12821 1/20 0.40
AOC3 Q16853 2/20 0.39
MGLL Q99685 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14928582 0.88 ACE (0.43) TRPA1MEN1KMT2ATSHRALDH1A1
SCHEMBL14928811 0.88 TRPA1 (0.42) TRPA1MEN1KMT2ATSHRALDH1A1
SCHEMBL14928453 0.85 TRPA1 (0.46) TRPA1MEN1KMT2ATSHRALDH1A1
SCHEMBL21444778 0.79 ADRA2B (0.56) TRPA1MEN1KMT2ATSHRALDH1A1
SCHEMBL7620970 0.79 ALDH1A1 (0.46) TRPA1MEN1KMT2ATSHRALDH1A1
SCHEMBL20333453 0.78 KMT2A (0.53) MEN1KMT2ATSHRALDH1A1ADRA2B
SCHEMBL5269298 0.76 TRPA1 (0.47) TRPA1MEN1KMT2ATSHRALDH1A1
SCHEMBL14909765 0.76 RIPK1 (0.47) MEN1KMT2AALDH1A1LMNARIPK1
SCHEMBL16165049 0.76 MEN1 (0.42) MEN1KMT2ATSHRALDH1A1LMNA
SCHEMBL5564292 0.75 ADRA2B (0.51) TRPA1MEN1KMT2ATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051310-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2015-06-09 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2014-10-16 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK TRPA1 1310/4885MEN1 2870/4885KMT2A 1162/4885
US-20140309225-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, BTK, NOX4 TRPA1 1881/4885MEN1 2984/4885KMT2A 1409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.